Paramore Miriam J

CIK 00017131561 companyROCHESTER, MI

SEC Profile

Transactions

Companies

Filings

CIK

0001713156

Recent Transactions

36 trades

Exercise/Conversion
OptimizeRx Corp$OPRX
Stock Option
2021-12-02$7.51/sh−3,558→ 90,760 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2021-12-02$7.51/sh+3,558→ 74,607 total
Sale
OptimizeRx Corp$OPRX
Common Stock Pursuant to 10B5-1 Plan
2021-12-02$61.48/sh−3,558→ 71,049 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Stock Option
2021-11-02−15,000→ 94,318 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2021-11-02$7.51/sh+15,000→ 89,607 total
Sale
OptimizeRx Corp$OPRX
Common Stock Pursuant to 10B5-1 Plan
2021-11-02$95.45/sh−15,000→ 74,607 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2021-10-04$7.51/sh+15,000→ 89,607 total
Sale
OptimizeRx Corp$OPRX
Common Stock Pursuant to 10B5-1 Plan
2021-10-04$84.67/sh−15,000→ 74,607 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Stock Option
2021-10-04−15,000→ 109,318 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Stock Option
2021-09-02−15,000→ 124,318 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2021-09-02$7.51/sh+15,000→ 89,607 total
Sale
OptimizeRx Corp$OPRX
Common Stock Pursuant to 10B5-1 Plan
2021-09-02$68.39/sh−15,000→ 74,607 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Stock Option
2021-08-02−15,000→ 139,318 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2021-08-02$7.51/sh+15,000→ 89,607 total
Sale
OptimizeRx Corp$OPRX
Common Stock Pursuant to 10B5-1 Plan
2021-08-02$55.76/sh−15,000→ 74,607 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Stock Option
2021-07-15−71,667→ 154,318 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2021-07-15$3.15/sh−67,195→ 74,607 total
Sale
OptimizeRx Corp$OPRX
Common Stock Pursuant to 10B5-1 Plan
2021-07-02$57.81/sh−15,000→ 7,412 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2021-07-02$3.15/sh+15,000→ 22,412 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Stock Option
2021-07-02−15,000→ 225,985 total
Sale
OptimizeRx Corp$OPRX
Common Stock Pursuant to 10B5-1 Plan
2021-06-04$51.30/sh−1,667→ 7,412 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2021-06-04$3.15/sh−13,333→ 20,745 total
Sale
OptimizeRx Corp$OPRX
Common Stock Pursuant to 10B5-1 Plan
2021-06-04$50.85/sh+13,333→ 7,412 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Stock Option
2021-06-04−13,333→ 240,985 total
Sale
OptimizeRx Corp$OPRX
Common Stock
2021-05-17$42.95/sh−15,000→ 9,079 total
Award
OptimizeRx Corp$OPRX
Stock Option
2021-01-07+24,093→ 254,318 total
Award
OptimizeRx Corp$OPRX
Stock Option
2020-03-11+63,558→ 230,225 total
Conversion
OptimizeRx Corp$OPRX
Contingent Stock Grant
2019-03-27−16,667→ 10,000 total
Award
OptimizeRx Corp$OPRX
Common Stock
2019-03-27+16,667→ 24,079 total
Award
OptimizeRx Corp$OPRX
Restricted Stock Grant
2019-02-25+10,000→ 26,667 total
Purchase
OptimizeRx Corp$OPRX
Common Stock
2018-12-19$9.85/sh+1,015→ 7,412 total
Purchase
OptimizeRx Corp$OPRX
Common Stock
2018-06-22$10.50/sh+100→ 6,397 total
Purchase
OptimizeRx Corp$OPRX
Common Stock
2018-06-15$8.05/sh+3,400→ 6,297 total
Purchase
OptimizeRx Corp$OPRX
Common Stock
2018-06-15$8.11/sh+1,600→ 7,897 total
Award
OptimizeRx Corp$OPRX
Restricted Stock Grant
2018-02-01+50,000→ 550,000 total
Purchase
OptimizeRx Corp$OPRX
Common Stock
2017-09-25$1.21/sh+8,690→ 8,690 total

Companies

OptimizeRx Corp
PRESIDENT
$OPRX

Recent Filings

Address

400 WATER STREET, SUITE 200

ROCHESTER, MI, 48307

View on SEC.gov